Immunic Inc (NASDAQ:IMUX)
| 6.12 Delayed Data As of May 27 |  +0.04 / +0.66%Today’s Change | 4.96 Today|||52-Week Range 15.12 | -36.05% Year-to-Date |
Latest IMUX News | Press Releases
No recent news for Immunic Inc.
Today’s Trading
| Previous close | 6.08 |
| Today’s open | 6.08 |
| Day’s range | 5.97 - 6.30 |
| Volume | 4,946 |
| Average volume (3 months) | 267,229 |
| Market cap | $176.5M |
Data as of 3:59pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -39.84% |
| Earnings growth (this year) | +25.49% |
| Earnings growth (next 5 years) | +15.51% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNFTGenfit SA | +0.30 | +8.80% |
| WWHCW World Corp | +0.04 | +2.22% |
| ---- | ||
| MRNSMarinus Pharmaceutic... | +0.10 | +2.00% |
Data as of 05/27/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$92.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
